|
(11) | EP 1 663 150 A2 |
(12) |
|
|
|
|
|||||||||||||||
(54) | NEUE INHALATIONSPULVER ENTHALTEND DEN CGRP-ANTAGONISTEN 1-[N2-[3,5-DIBROM-N-[[4-(3,4-DIHYDRO-2(1H)-OXOCHINAZOLIN-3-YL)-1-PIPERIDINY]CARBONYL]-D-TYROSYL]-L-LYSYL]-4-(4-PYRIDINYL)-PIPERAZIN |